Abstract
Purpose To determine the clinical efficacy of frequency-doubled Nd:YAG (FD YAG) laser for the treatment of diabetic clinically significant macular oedema (CSMO).
Methods A prospective pilot study was carried out on 55 eyes with CSMO. FD YAG laser exposures were applied in a focal or grid pattern. The results were evaluated by Snellen visual acuity, slit-lamp biomicroscopy, colour photography and fundus fluorescein angiography.
Results At mean review of 5.3 months, macular oedema had resolved either completely or partly in 44 (80%) eyes, was unchanged in 10 (18%) eyes and progressed in 1 (2%) eye. Visual acuity improved in 11 (20%), stabilised in 40 (73%) and deteriorated in 4 (7%) eyes.
Conclusion FD YAG laser therapy is effective in the treatment of CSMO. It combines the ergonomie advantages of a solid-state laser with the benefits of its wavelength. A comparison between the clinical results of FD YAG and other lasers used in the treatment of CSMO is, however, required.
Similar content being viewed by others
Article PDF
References
Early Treatment of Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report 9. Ophthalmology (Suppl) 1991;98:766–85.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular oedema. ETDRS Report 1. Arch Ophthalmol 1985;103:1796–806.
Resser F, Fleishman J, Williams GA, Goldmann A . Efficacy of argon laser photocoagulation in the treatment of circinate diabetic retinopathy. Am J Ophthalmol 1981;92:762–7.
Olk RJ . Argon-green (514 nm) versus krypton-red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular oedema. Ophthalmology 1990;97:1101–13.
Ulbig MW, McHugh DA, Hamilton AMP . Diode laser photocoagulation for diabetic macular oedema. Br J Ophthalmol 1995;79:318–21.
McCullen WW, Garcia CA . Comparison of retinal photocoagulation using pulsed frequency-doubled neodymium-YAG and argon green laser. Retina 1992;12:265–9.
Brancato R, Bandello F, Trabucchi G, Lattanzio R . Frequency doubled Nd:YAG laser versus argon-green laser photocoagulation in proliferative diabetic retinopathy: a preliminary report. Lasers Light Ophthalmol 1991;4:97–102.
Abreu MM, Sierra RA, Netland PA . Diode laser-pumped, frequency-doubled neodymium:YAG laser peripheral iridotomy. Ophthalmic Surg Lasers 1997;28:305–10.
L'Esperance FA Jr. Clinical photocoagulation with the frequency-doubled neodymium yttrium-aluminium-garnet laser. Am J Ophthalmol 1971;71:631–8.
Mosier MA, Champion J, Liaw LH, Berns MW . Retinal effects of the frequency-doubled (532 nm) YAG laser: histopathological comparison with argon laser. Lasers Surg Med 1985;5:377–404.
Puliafito CA, Adler CM, Steinert RF . Experimental retinal photocoagulation with a frequency-doubled neodymium-YAG and argon green laser. Invest Ophthalmol Vis Sci (Suppl) 1985;26:38.
Obana A, et al. An experimental and clinical study of chorioretinal photocoagulation using a frequency-doubled Nd:YAG laser. Nippon Ganka Gakki Zasshi 1993;97:1040–6.
Okuyama M, Okisaka S, Ito M . Comparative study on frequency-doubled Nd:YAG laser, krypton laser and diode laser for diabetic maculopathy. Nippon Ganka Gakkai Zasshi 1995;99:87–92.
Olk RJ . Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular oedema. Ophthalmology 1986;93:938–50.
McHugh JDA, Marshal J, Ffytche TJ, Hamilton AM, Raven A, Keeler CR . Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye 1989;3:516–27.
Brancato R, Patresi R, Leoni G, Trabucchi G, Giovannoni L, Vanni U . Retinal photocoagulation with diode laser operating from a slit-lamp microscope. Lasers Light Ophthalmol 1988;2:73–8.
McHugh JDA, Marshall J, Capon M, Rothery S, Raven A, Naylor RP . Transpupillary retinal photocoagulation in the eyes of rabbit and human using a diode laser. Lasers Light Ophthalmol 1988;2:125–43.
Chew EY . Treatment of diabetic macular oedema with krypton laser photocoagulation. In: Gitter KA et al., editors. Laser photocoagulation of retinal disease. In: International laser symposium of the macula (New Orleans, LA, 1986). San Francisco: Pacific Medical Press, 1988:83–7.
Cruess AF, William JC, Willan AR . Argon green and krypton red laser treatment of diabetic macular oedema. Can J Ophthalmol 1988;23:262–6.
Pomerantzeff O, Kaneko H, Donovan RH, et al. Effects of the ocular media on the main wavelengths of argon laser emission. Invest Ophthalmol Vis Sci 1976;15:70–7.
Trempe CL, Mainster MA, Pomperantzeff O, et al. Macular photocoagulation: Optimal wavelength selection. Ophthalmology 1982;89:721–8.
Mainster MA . Wavelength in macular photocoagulation: tissue optics, thermal effects, and laser systems. Ophthalmology 1986;93:952–8.
Jalkh AE, Pflibsen K, Pomperantzell O, Trempe CL, Schepens CL . A new solid-state, frequency doubled neodymium:YAG photocoagulation system. Arch Ophthalmol 1988;106:847–9.
Author information
Authors and Affiliations
Additional information
Previously presented as a Free Paper at the Annual Congress of the Royal College of Ophthalmologists, Cardiff, may 1998
Rights and permissions
About this article
Cite this article
Saeed, M., Parmar, D. & McHugh, D. Frequency-doubled Nd:YAG laser for the treatment of exudative diabetic maculopathy. Eye 15, 712–718 (2001). https://doi.org/10.1038/eye.2001.235
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.2001.235